We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Tribe, Drugmaker Ask Justices To Overturn Bar On Sovereign Immunity IPR Protection

Mealey's (January 15, 2019, 2:45 PM EST) -- WASHINGTON, D.C. — The Federal Circuit U.S. Court of Appeals’ ruling that an Indian tribe’s sovereign immunity cannot shield a drug company from inter partes review (IPR) of patents should be...
To view the full article, register now.